Novel precision-based treatments for biliary tract cancer [ 1/1/2021 - 12/31/2023 ]

Research Grant

Brief description Advanced biliary tract cancer has a median life-expectancy of ~12 months. The relatively low incidence of the disease in Australia requires a collaborative team-based approach to drive progress. To achieve this, we have established a multidisciplinary research team based in Australia, Thailand and Japan. Here, we will now build on our exciting preliminary discoveries to test new patient-specific treatments, and develop methods to efficiently identify patients who may respond to immunotherapy.

Funding Amount $644,241

Funding Scheme International Collaborations

Chief Investigator Prof John Mariadason

Notes NHMRC e-ASIA Joint Research Program